338 related articles for article (PubMed ID: 23600632)
1. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
[TBL] [Abstract][Full Text] [Related]
2. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
3. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
4. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.
Alper AT; Hasdemir H; Sahin S; Ontürk E; Akyol A; Nurkalem Z; Cakmak N; Erdinler I; Gürkan K
Turk Kardiyol Dern Ars; 2008 Sep; 36(6):376-81. PubMed ID: 19155640
[TBL] [Abstract][Full Text] [Related]
5. Presence of coronary plaques in patients with nonalcoholic fatty liver disease.
Assy N; Djibre A; Farah R; Grosovski M; Marmor A
Radiology; 2010 Feb; 254(2):393-400. PubMed ID: 20093511
[TBL] [Abstract][Full Text] [Related]
6. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
[TBL] [Abstract][Full Text] [Related]
7. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
8. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.
Haukeland JW; Dahl TB; Yndestad A; Gladhaug IP; Løberg EM; Haaland T; Konopski Z; Wium C; Aasheim ET; Johansen OE; Aukrust P; Halvorsen B; Birkeland KI
Eur J Endocrinol; 2012 Mar; 166(3):503-10. PubMed ID: 22170794
[TBL] [Abstract][Full Text] [Related]
9. Association between non-alcoholic fatty liver disease and coronary artery disease severity.
Sun L; Lü SZ
Chin Med J (Engl); 2011 Mar; 124(6):867-72. PubMed ID: 21518594
[TBL] [Abstract][Full Text] [Related]
10. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
[TBL] [Abstract][Full Text] [Related]
11. Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.
Sato M; Kamada Y; Takeda Y; Kida S; Ohara Y; Fujii H; Akita M; Mizutani K; Yoshida Y; Yamada M; Hougaku H; Takehara T; Miyoshi E
Liver Int; 2015 Mar; 35(3):925-35. PubMed ID: 25627311
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
[TBL] [Abstract][Full Text] [Related]
13. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
[TBL] [Abstract][Full Text] [Related]
14. Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes.
Zhao ZW; Lin CG; Wu LZ; Luo YK; Fan L; Dong XF; Zheng H
Biomarkers; 2013 Mar; 18(2):160-4. PubMed ID: 23410047
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes.
Boddi M; Tarquini R; Chiostri M; Marra F; Valente S; Giglioli C; Gensini GF; Abbate R
Eur J Clin Invest; 2013 May; 43(5):429-38. PubMed ID: 23480577
[TBL] [Abstract][Full Text] [Related]
17. Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients.
Jiang ZY; Xu CY; Chang XX; Li WW; Sun LY; Yang XB; Yu LF
BMC Gastroenterol; 2013 Jul; 13():110. PubMed ID: 23834773
[TBL] [Abstract][Full Text] [Related]
18. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.
Yang W; Huang H; Wang Y; Yu X; Yang Z
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):174-8. PubMed ID: 24025980
[TBL] [Abstract][Full Text] [Related]
19. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.
Reinehr T; Roth CL
J Clin Endocrinol Metab; 2008 Nov; 93(11):4479-85. PubMed ID: 18728159
[TBL] [Abstract][Full Text] [Related]
20. Association between nonalcoholic fatty liver disease and coronary artery disease.
Arslan U; Türkoğlu S; Balcioğlu S; Tavil Y; Karakan T; Cengel A
Coron Artery Dis; 2007 Sep; 18(6):433-6. PubMed ID: 17700213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
